CINNASIL Drug Patent Profile
✉ Email this page to a colleague
When do Cinnasil patents expire, and when can generic versions of Cinnasil launch?
Cinnasil is a drug marketed by Panray and is included in one NDA.
The generic ingredient in CINNASIL is rescinnamine. There is one drug master file entry for this compound. Additional details are available on the rescinnamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CINNASIL?
- What are the global sales for CINNASIL?
- What is Average Wholesale Price for CINNASIL?
Summary for CINNASIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 1,100 |
| DailyMed Link: | CINNASIL at DailyMed |
US Patents and Regulatory Information for CINNASIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panray | CINNASIL | rescinnamine | CAPSULE;ORAL | 084736-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
